162 related articles for article (PubMed ID: 16331610)
1. Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma.
Kang S; Kim JW; Kang GH; Lee S; Park NH; Song YS; Park SY; Kang SB; Lee HP
Int J Cancer; 2006 May; 118(9):2168-71. PubMed ID: 16331610
[TBL] [Abstract][Full Text] [Related]
2. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix.
Dong SM; Kim HS; Rha SH; Sidransky D
Clin Cancer Res; 2001 Jul; 7(7):1982-6. PubMed ID: 11448914
[TBL] [Abstract][Full Text] [Related]
4. Quantitative assessment of DNA methylation for the detection of cervical and endometrial adenocarcinomas in liquid-based cytology specimens.
Kim GE; Kweon SS; Lee JS; Lee JH; Nam JH; Choi C
Anal Quant Cytopathol Histpathol; 2012 Aug; 34(4):195-203. PubMed ID: 23016466
[TBL] [Abstract][Full Text] [Related]
5. Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma.
Kang S; Kim HS; Seo SS; Park SY; Sidransky D; Dong SM
Gynecol Oncol; 2007 Jun; 105(3):662-6. PubMed ID: 17360030
[TBL] [Abstract][Full Text] [Related]
6. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
De Schutter H; Geeraerts H; Verbeken E; Nuyts S
Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of detection of tumor suppressor genes aberrant methylation in cervical carcinoma tissue].
Xu J; Wang HL; Lu GC; Wang ZJ; Lin X; Zhou HW
Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):394-7. PubMed ID: 17697601
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.
Yu MY; Tong JH; Chan PK; Lee TL; Chan MW; Chan AW; Lo KW; To KF
Int J Cancer; 2003 Jun; 105(2):204-9. PubMed ID: 12673680
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of the COX-2 gene is a potential prognostic marker for cervical cancer.
Jo H; Kang S; Kim JW; Kang GH; Park NH; Song YS; Park SY; Kang SB; Lee HP
J Obstet Gynaecol Res; 2007 Jun; 33(3):236-41. PubMed ID: 17578348
[TBL] [Abstract][Full Text] [Related]
11. Relationship of the aberrant DNA hypermethylation of cancer-related genes with carcinogenesis of endometrial cancer.
Banno K; Yanokura M; Susumu N; Kawaguchi M; Hirao N; Hirasawa A; Tsukazaki K; Aoki D
Oncol Rep; 2006 Dec; 16(6):1189-96. PubMed ID: 17089036
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of human riboflavin transporter 2(hRFT2) in cervical cancers from Uighur women.
Ma JQ; Kurban S; Zhao JD; Li QZ; Hasimu A
Asian Pac J Cancer Prev; 2014; 15(6):2485-9. PubMed ID: 24761851
[TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
14. Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics.
Jeong DH; Youm MY; Kim YN; Lee KB; Sung MS; Yoon HK; Kim KT
Int J Gynecol Cancer; 2006; 16(3):1234-40. PubMed ID: 16803511
[TBL] [Abstract][Full Text] [Related]
15. Distinct DNA methylation profiles between adenocarcinoma and squamous cell carcinoma of human uterine cervix.
Lee EJ; Mcclelland M; Wang Y; Long F; Choi SH; Lee JH
Oncol Res; 2010; 18(9):401-8. PubMed ID: 20524398
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of tumor-related genes hypermethylation detected in cancer-free surgical margins of oral squamous cell carcinomas.
Supic G; Kozomara R; Jovic N; Zeljic K; Magic Z
Oral Oncol; 2011 Aug; 47(8):702-8. PubMed ID: 21697000
[TBL] [Abstract][Full Text] [Related]
17. Assessment of gene promoter hypermethylation for detection of cervical neoplasia.
Wisman GB; Nijhuis ER; Hoque MO; Reesink-Peters N; Koning AJ; Volders HH; Buikema HJ; Boezen HM; Hollema H; Schuuring E; Sidransky D; van der Zee AG
Int J Cancer; 2006 Oct; 119(8):1908-14. PubMed ID: 16736496
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer.
Kang S; Kim JW; Kang GH; Park NH; Song YS; Kang SB; Lee HP
Gynecol Oncol; 2005 Jan; 96(1):173-80. PubMed ID: 15589597
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic inactivation of the CHFR gene in cervical cancer contributes to sensitivity to taxanes.
Banno K; Yanokura M; Kawaguchi M; Kuwabara Y; Akiyoshi J; Kobayashi Y; Iwata T; Hirasawa A; Fujii T; Susumu N; Tsukazaki K; Aoki D
Int J Oncol; 2007 Oct; 31(4):713-20. PubMed ID: 17786301
[TBL] [Abstract][Full Text] [Related]
20. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.
Wong ML; Tao Q; Fu L; Wong KY; Qiu GH; Law FB; Tin PC; Cheung WL; Lee PY; Tang JC; Tsao GS; Lam KY; Law S; Wong J; Srivastava G
Int J Oncol; 2006 Mar; 28(3):767-73. PubMed ID: 16465383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
